Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Midazolam Injection

Approval Number

国药准字H20243614

Company福安药业集团庆余堂制药有限公司

Registration Date

April 24, 2024

Drug Information

Generic Name

咪达唑仑注射液

Dosage Form

注射剂

Strength

1ml：5mg（按C₁₈H₁₃ClFN₃计）

Drug Type

化学药品

Registration Date

April 24, 2024

Company Information

Applicant Company

Company Name福安药业集团庆余堂制药有限公司

Company Address

重庆市渝北区黄杨路2号

Manufacturing Company

Company Name福安药业集团庆余堂制药有限公司

Company Address

重庆市渝北区黄杨路2号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy